Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 4
Submit an article Journal homepage
26
Views
1
CrossRef citations to date
0
Altmetric
Case Studies

Mycobacterium bovis epidural abscess following Bacillus Calmette-Guerin therapy for bladder cancer

Hanish JainDepartment of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, New YorkCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-2144-9056
, MDORCID Icon,
Kunal GadaDepartment of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, New YorkORCID Iconhttp://orcid.org/0000-0003-2423-3303
, MBBSORCID Icon,
Syed ZaidiDepartment of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, New YorkORCID Iconhttp://orcid.org/0000-0003-4436-2241
, MDORCID Icon,
Elizabeth Asiago-ReddyDepartment of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, New York
, MD &
Ambika ErankiDepartment of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, New York
, MD, MPH
Pages 577-578 | Received 29 May 2019, Accepted 22 Jul 2019, Published online: 12 Aug 2019

  • Fuge O, Vasdev N, Allchorne P, Green J. Immunotherapy for bladder cancer. Res Rep Urol. 2015;7:65–79. doi: 10.2147/RRU.S63447.
  • Jones Z, Fazili T, Eranki A. Pott’s disease caused by Mycobacterium bovis following intravesical BCG therapy for bladder cancer. Open Forum Infect Dis. 2017;4(suppl_1):S676. doi: 10.1093/ofid/ofx163.1807.
  • Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992;147(Part 1):596–600. doi: 10.1016/S0022-5347(17)37316-0.
  • Hakim S, Heaney JA, Heinz T, Zwolak RW. Psoas abscess following intravesical Bacillus Calmette-Guerin for bladder cancer: a case report. J Urol. 1993;150:188–189. doi: 10.1016/S0022-5347(17)35432-0.
  • Lamm DL. Complications of Bacillus Calmette-Guérin immunotherapy. Urol Clin North Am. 1992;19:565–572.
  • Bowyer L, Hall RR, Reading J, Marsh MM. The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer. Br J Urol. 1995;75:188–192. doi: 10.1111/j.1464-410X.1995.tb07309.x.
  • Obaid S, Weil AG, Rahme R, Gendron C, Shedid D. Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy. Surg Neurol Int. 2011;2:162. doi: 10.4103/2152-7806.89879.
  • Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, et al. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore). 2014;93:236–254. doi: 10.1097/MD.0000000000000119.
  • Mavrogenis AF, Sakellariou VI, Tsiodras S, Papagelopoulos PJ. Late Mycobacterium bovis spondylitis after intravesical BCG therapy. Joint Bone Spine. 2009;76:296–300. doi: 10.1016/j.jbspin.2008.10.011.
  • Abu-Nader R, Terrell CL. Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use. Mayo Clin Proc. 2002;77:393–397. doi: 10.4065/77.4.393.
  • Aljada IS, Crane JK, Corriere N, Wagle DG, Amsterdam D. Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott’s disease) following intravesical BCG therapy. J Clin Microbiol. 1999;37:2106–2108.
  • Civen R, Berlin G, Panosian C. Vertebral osteomyelitis after intravesical administration of bacille Calmette-Guérin. Clin Infect Dis. 1994;18:1013–1014. doi: 10.1093/clinids/18.6.1013.
  • Josephson CB, Al-Azri S, Smyth DJ, Haase D, Johnston BL. A case of Pott’s disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer. Can J Infect Dis Med Microbiol. 2010;21:e75–e78. doi: 10.1155/2010/572410.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.